Back
OrthoPediatrics Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
29
KIDS
OrthoPediatrics
Last Price:
22.68
Seasonality Move:
4.08%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereOrthoPediatrics Price Quote
$22.68
-1.57 (-6.47%)
(Updated: November 14, 2024 at 5:55 PM ET)
OrthoPediatrics Key Stats
Sell
29
OrthoPediatrics (KIDS)
is a Sell
Day range:
$23.92 - $24.64
52-week range:
$23.77 - $36.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.91
P/B ratio:
1.57%
Volume:
148.6K
Avg. volume:
154.7K
1-year change:
-6.98%
Market cap:
$582.2M
Revenue:
$148.7M
EPS:
$-1.23
How Much Does OrthoPediatrics Make?
-
How Much Are OrthoPediatrics's Sales Annually?
KIDS Revenues are $148.7M -
How Much Profit Does OrthoPediatrics's Make A Year?
KIDS net income is -$21M
Is OrthoPediatrics Growing As A Company?
-
What Is OrthoPediatrics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.37% -
What Is OrthoPediatrics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
OrthoPediatrics Stock Price Performance
-
Did OrthoPediatrics Stock Go Up Last Month?
OrthoPediatrics share price went down by -1.46% last month -
Did KIDS's Share Price Rise Over The Last Year?
KIDS share price fell by -6.98% over the past 1 year
What Is OrthoPediatrics 52-Week High & Low?
-
What Is OrthoPediatrics’s 52-Week High Share Price?
OrthoPediatrics has traded as high as $36.23 over the past 52 weeks -
What Is OrthoPediatrics’s 52-Week Low Share Price?
OrthoPediatrics has traded as low as $23.77 over the past 52 weeks
OrthoPediatrics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy OrthoPediatrics?
-
How Much Debt Does OrthoPediatrics Have?
Total long term debt quarterly is $72.7M -
How Much Cash Does OrthoPediatrics Have?
Cash and short term investments quarterly total is $76.1M -
What Is OrthoPediatrics’s Book Value Per Share?
Book value per share is 15.32
Is OrthoPediatrics Cash Flow Positive?
-
What Is KIDS Cash Flow From Operations?
Cash flow from operations (TTM) is -$30.6M -
What Is OrthoPediatrics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $63.1M -
What Is OrthoPediatrics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $7.2M
OrthoPediatrics Return On Invested Capital
-
Is Management Doing A Good Job?
KIDS return on invested capital is -7.23% -
What Is OrthoPediatrics Return On Assets?
ROA measures how assets are converting to revenues and is -6.38% -
What Is KIDS Return On Equity?
ROE is a measure of profitability and is -7.63%
OrthoPediatrics Earnings Date & Stock Price
-
What Is OrthoPediatrics's Stock Price Today?
A single share of KIDS can be purchased today for 24.25 -
What Is OrthoPediatrics’s Stock Symbol?
OrthoPediatrics trades on the nasdaq under the ticker symbol: KIDS -
When Is OrthoPediatrics’s Next Earnings Date?
The next quarterly earnings date for OrthoPediatrics is scheduled on March 6, 2025 -
When Is KIDS's next ex-dividend date?
OrthoPediatrics's next ex-dividend date is May 26, 2020 -
How To Buy OrthoPediatrics Stock?
You can buy OrthoPediatrics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
OrthoPediatrics Competitors
-
Who Are OrthoPediatrics's Competitors?
Below is a list of companies who compete with OrthoPediatrics or are related in some way:
OrthoPediatrics Dividend Yield
-
What Is KIDS Dividend Yield?
OrthoPediatrics’s dividend yield currently is 0% -
What Is OrthoPediatrics’s Payout Ratio?
OrthoPediatrics’s payout ratio is 0% -
When Did OrthoPediatrics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is OrthoPediatrics’s Dividend Per Share?
OrthoPediatrics pays a dividend of $0.00 per share
OrthoPediatrics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 5.26% |
| Revenue: | 36.53% | 1.64% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 40.67 |
| Upside from Last Price: | 67.7% |